[{"from": "human", "value": "Provide a brief overview of this molecule. [C][=N][C][=Branch2][Ring1][#Branch2][=C][Branch2][Ring1][Branch1][N][Ring1][Branch1][C@H1][C@@H1][Branch1][=N][C@@H1][Branch1][=Branch2][C@H1][Branch1][Ring2][O][Ring1][Branch1][C][O][O][O][N][C][=Branch1][C][=O][N]"}, {"from": "gpt", "value": "The molecule is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing coronary artery bypass graft (CABG) surgery. It is being developed jointly by PeriCor and Schering-Plough. Acadesine has been granted Orphan Drug Designation for B-CLL in the EU."}]